|
1
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar
|
|
2
|
Butcher EC, Williams M, Youngman K, Rott L
and Briskin M: Lymphocyte trafficking and regional immunity. Adv
Immunol. 72:209–253. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Campbell JJ and Butcher EC: Chemokines in
tissue-specific and microenvironment-specific lymphocyte homing.
Curr Opin Immunol. 12:336–341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morales J, Homey B, Vicari AP, et al:
CTACK, a skin-associated chemokine that preferentially attracts
skin-homing memory T cells. Proc Natl Acad Sci USA. 96:14470–14475.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mburu YK, Abe K, Ferris LK, Sarkar SN and
Ferris RL: Human β-defensin 3 promotes NF-κB-mediated CCR7
expression and anti-apoptotic signals in squamous cell carcinoma of
the head and neck. Carcinogenesis. 32:168–174. 2011.
|
|
7
|
Nagira M, Imai T, Yoshida R, et al: A
lymphocyte-specific CC chemokine, secondary lymphoid tissue
chemokine (SLC), is a highly efficient chemoattractant for B cells
and activated T cells. Eur J Immunol. 28:1516–1523. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iijima N, Yanagawa Y, Clingan JM and Onoé
K: CCR7-mediated c-Jun N-terminal kinase activation regulates cell
migration in mature dendritic cells. Int Immunol. 17:1201–1212.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Emmett MS, Lanati S, Dunn DB, Stone OA and
Bates DO: CCR7 mediates directed growth of melanomas towards
lymphatics. Microcirculation. 18:172–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding Y, Shimada Y, Maeda M, et al:
Association of CC chemokine receptor 7 with lymph node metastasis
of esophageal squamous cell carcinoma. Clin Cancer Res.
9:3406–3412. 2003.PubMed/NCBI
|
|
11
|
Takanami I: Overexpression of CCR7 mRNA in
nonsmall cell lung cancer: correlation with lymph node metastasis.
Int J Cancer. 105:186–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami T, Cardones AR and Hwang ST:
Chemokine receptors and melanoma metastasis. J Dermatol Sci.
36:71–78. 2004. View Article : Google Scholar
|
|
13
|
Gunther K, Leier J, Henning G, et al:
Prediction of lymph node metastasis in colorectal carcinoma by
expression of chemokine receptor CCR7. Int J Cancer. 116:726–733.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cabioglu N, Yazici MS, Arun B, et al: CCR7
and CXCR4 as novel biomarkers predicting axillary lymph node
metastasis in T1 breast cancer. Clin Cancer Res. 11:5686–5693.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schimanski CC, Bahre R, Gockel I, et al:
Chemokine receptor CCR7 enhances intrahepatic and lymphatic
dissemination of human hepatocellular cancer. Oncol Rep.
16:109–113. 2006.PubMed/NCBI
|
|
16
|
Zhao ZJ, Li P, Liu FY, Sun LY and Sun CF:
PKCα take part in CCR7/NF-κB autocrine signaling loop in
CCR7-positive squamous cell carcinoma of head and neck. Mol Cell
Biochem. 357:181–187. 2011.
|
|
17
|
Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and
Sun CF: CCL19-induced chemokine receptor 7 activates the
phosphoinositide-3 kinase-mediated invasive pathway through Cdc42
in metastatic squamous cell carcinoma of the head and neck. Oncol
Rep. 25:729–737. 2011.PubMed/NCBI
|
|
18
|
Li P, Zhao ZJ, Liu FY, et al: The
chemokine receptor 7 regulates cell adhesion and migration via
beta1 integrin in metastatic squamous cell carcinoma of the head
and neck. Oncol Rep. 24:989–995. 2010.PubMed/NCBI
|
|
19
|
Li P, Liu F, Sun L, et al: Chemokine
receptor 7 promotes cell migration and adhesion in metastatic
squamous cell carcinoma of the head and neck by activating integrin
αvβ3. Int J Mol Med. 27:679–687. 2011.PubMed/NCBI
|
|
20
|
Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and
Sun CF: Mammalian target of rapamycin (mTOR) is involved in the
survival of cells mediated by chemokine receptor 7 through PI3K/Akt
in metastatic squamous cell carcinoma of the head and neck. Br J
Oral Maxillofac Surg. 48:291–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu FY, Zhao ZJ, Li P, Ding X and Sun CF:
Effect of rapamycin combined with cisplatin on head and neck
squamous cancer cells regulated by CCL19. Zhonghua Kou Qiang Yi Xue
Za Zhi. 46:197–200. 2011.(In Chinese).
|
|
22
|
Liu FY, Zhao ZJ, Li P, Ding X and Sun CF:
The effect of CCL19 on the viability of head and neck squamous
cancer cells. Shanghai Kou Qiang Yi Xue. 19:158–161. 2010.(In
Chinese).
|
|
23
|
Liu FY, Zhao ZJ, Li P, et al: NF-κB
participates in chemokine receptor 7-mediated cell survival in
metastatic squamous cell carcinoma of the head and neck. Oncol Rep.
25:383–391. 2011.
|
|
24
|
Liu FY, Zhao ZJ, Huang SH and Sun CF: Role
of PDTC in CCL19 regulating the activity of human head and neck
squamous cancer cells. J Chin Med Univ. 37:847–849. 2008.(In
Chinese).
|
|
25
|
Thelen M: Dancing to the tune of
chemokines. Nat Immunol. 2:129–134. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ganju RK, Brubaker SA, Meyer J, et al: The
alpha-chemokine, stromal cell-derived factor-1alpha, binds to the
transmembrane G-protein-coupled CXCR-4 receptor and activates
multiple signal transduction pathways. J Biol Chem.
273:23169–23175. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ganju RK, Dutt P, Wu L, et al:
Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase
RAFTK. Blood. 91:791–797. 1998.PubMed/NCBI
|
|
28
|
Wong MM and Fish EN: Chemokines:
attractive mediators of the immune response. Semin Immunol.
15:5–14. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang P, Han J and Hui L: MAPK signaling
in inflammation-associated cancer development. Protein Cell.
1:218–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Klemke RL, Cai S, Giannini AL, Gallagher
PJ, de Lanerolle P and Cheresh DA: Regulation of cell motility by
mitogen-activated protein kinase. J Cell Biol. 137:481–492. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang C, Rajfur Z, Borchers C, Schaller MD
and Jacobson K: JNK phosphorylates paxillin and regulates cell
migration. Nature. 424:219–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Wu C, Wan S, Zhang H, Zhou S and
Liu G: Shikonin attenuates lung cancer cell adhesion to
extracellular matrix and metastasis by inhibiting integrin β1
expression and the ERK1/2 signaling pathway. Toxicology.
308:104–112. 2013.PubMed/NCBI
|
|
33
|
Wang J, Zhang X, Thomas SM, et al:
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated
invasive and prosurvival pathways in head and neck cancer cells
independent of EGFR. Oncogene. 24:5897–5904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mburu YK, Wang J, Wood MA, Walker WH and
Ferris RL: CCR7 mediates inflammation-associated tumor progression.
Immunol Res. 36:61–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: an imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ngo VN, Tang HL and Cyster JG:
Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed
by dendritic cells in lymphoid tissues and strongly attracts naive
T cells and activated B cells. J Exp Med. 188:181–191. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Johnson GL: Defining MAPK interactomes.
ACS Chem Biol. 6:18–20. 2011. View Article : Google Scholar
|
|
38
|
Riol-Blanco L, Sánchez-Sánchez N, Torres
A, et al: The chemokine receptor CCR7 activates in dendritic cells
two signaling modules that independently regulate chemotaxis and
migratory speed. J Immunol. 174:4070–4080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shannon LA, Calloway PA, Welch TP and
Vines CM: CCR7/CCL21 migration on fibronectin is mediated by
phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes. J Biol
Chem. 285:38781–38787. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Redondo-Muñoz J, José Terol M,
García-Marco JA and García-Pardo A: Matrix metalloproteinase-9 is
up-regulated by CCL21/CCR7 interaction via extracellular
signa-lregulated kinase-1/2 signaling and is involved in
CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and
migration. Blood. 111:383–386. 2008.
|
|
41
|
Johnson GL, Dohlman HG and Graves LM: MAPK
kinase kinases (MKKKs) as a target class for small-molecule
inhibition to modulate signaling networks and gene expression. Curr
Opin Chem Biol. 9:325–331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Takayama T, Shiozaki H, Shibamoto S, et
al: Beta-catenin expression in human cancers. Am J Pathol.
148:39–46. 1996.
|
|
43
|
Savagner P: Leaving the neighborhood:
molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Behrens J: Cadherins and catenins: role in
signal transduction and tumor progression. Cancer Metastasis Rev.
18:15–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng JC, Klausen C and Leung PC: Hydrogen
peroxide mediates EGF-induced down-regulation of E-cadherin
expression via p38 MAPK and snail in human ovarian cancer cells.
Mol Endocrinol. 24:1569–1580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen XF, Zhang HJ, Wang HB, et al:
Transforming growth factor-β1 induces epithelial-to-mesenchymal
transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2
signaling pathways. Mol Biol Rep. 39:3549–3556. 2011.
|
